Sundial Growers Operating Expenses 2011-2026 | SNDL

Annual Operating Expenses Sundial Growers

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	102 K	191 K	393 K	2.96 M	11.1 M	-	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
11.1 M	102 K	2.94 M

Operating Expenses of other stocks in the Drug manufacturers industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	40.3 M	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	38.9 M	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	30.5 M	-	10.11 %	$ 58.2 M	USA
Aerie Pharmaceuticals AERI	213 M	-	-	$ 754 M	USA
Alimera Sciences ALIM	71.8 M	-	-	$ 142 M	USA
Canopy Growth Corporation CGC	197 M	$ 1.14	-4.62 %	$ 123 M	Canada
Cronos Group CRON	154 M	$ 2.56	1.24 %	$ 1.35 B	Canada
Cumberland Pharmaceuticals CPIX	35.2 M	$ 4.74	1.94 %	$ 66.6 M	USA
Catalent CTLT	512 M	-	-	$ 11.5 B	USA
Eagle Pharmaceuticals EGRX	113 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	763 M	-	-	$ 28.9 M	Irlanda
Calliditas Therapeutics AB (publ) CALT	213 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	106 M	-	2.45 %	$ 38.1 M	Canada
Evoke Pharma EVOK	12.6 M	-	-	$ 36.6 M	USA
DURECT Corporation DRRX	44.6 M	-	-	$ 50.1 M	USA
Emergent BioSolutions EBS	558 M	$ 11.08	0.82 %	$ 567 M	USA
Athenex ATNX	96.7 M	-	-23.39 %	$ 1.76 M	USA
Evolus EOLS	107 M	$ 5.05	-2.88 %	$ 313 M	USA
Harrow Health HROW	90.1 M	$ 47.49	-0.86 %	$ 1.55 B	USA
China Pharma Holdings CPHI	2.6 M	$ 1.25	-	$ 21.8 M	China
Jupiter Wellness JUPW	39.6 M	-	-	$ 33.6 M	USA
OrganiGram Holdings OGI	41.4 M	$ 1.62	0.62 %	$ 402 M	Canada
Bausch Health Companies BHC	4.96 B	$ 6.75	-3.3 %	$ 2.46 B	Canada
Neoleukin Therapeutics NLTX	55.6 M	-	-	$ 193 M	Canada
Lannett Company LCI	209 M	-	1.15 %	$ 7.11 M	USA
Organogenesis Holdings ORGO	368 M	$ 3.64	-3.96 %	$ 479 M	USA
Pacira BioSciences PCRX	279 M	$ 19.43	1.38 %	$ 899 M	USA
Avadel Pharmaceuticals plc AVDL	196 M	$ 21.51	0.14 %	$ 2.05 B	France
PetIQ PETQ	138 M	-	1.64 %	$ 400 M	USA
Perrigo Company plc PRGO	1.43 B	$ 15.06	0.2 %	$ 2.07 B	USA
Aurora Cannabis ACB	183 M	$ 4.14	-2.13 %	$ 86.3 M	Canada
ProPhase Labs PRPH	47.1 M	-	-	$ 5.07 M	USA
Recro Pharma REPH	22.5 M	-	-4.76 %	$ 65.3 M	USA
Rockwell Medical RMTI	31.1 M	$ 1.22	27.44 %	$ 28.5 M	USA
Radius Health RDUS	304 M	-	-	$ 1.42 B	USA
Sonoma Pharmaceuticals SNOA	9.18 M	$ 3.33	1.06 %	$ 4.13 M	USA
Relmada Therapeutics RLMD	104 M	$ 3.93	5.01 %	$ 118 M	USA
OptiNose OPTN	129 M	-	-	$ 1.08 B	USA
Assertio Holdings ASRT	133 M	$ 12.04	4.88 %	$ 855 M	USA
Tilray TLRY	1.52 B	$ 8.74	-7.62 %	$ 5.4 B	Canada
PLx Pharma PLXP	44.2 M	-	-27.8 %	$ 2.56 M	USA
Solid Biosciences SLDB	130 M	$ 5.59	2.19 %	$ 228 M	USA
SCYNEXIS SCYX	67.5 M	$ 0.65	-0.68 %	$ 31.1 M	USA
Tricida TCDA	153 M	-	-	$ 3.25 M	USA
Veru VERU	44 M	$ 2.53	-5.95 %	$ 341 M	USA
TherapeuticsMD TXMD	9.82 M	$ 2.55	14.39 %	$ 26.6 M	USA
Viatris VTRS	4.88 B	$ 12.66	-1.59 %	$ 15.3 B	USA
Zomedica Corp. ZOM	14.1 M	-	-0.21 %	$ 98 M	USA
cbdMD YCBD	28.9 M	$ 0.83	-9.94 %	$ 3.58 M	USA